
Enovis Corp
NYSE:ENOV

Enovis Corp?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
Energy
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
30.66
50.27
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.

What unique competitive advantages
does Enovis Corp hold over its rivals?
What risks and challenges
does Enovis Corp face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Enovis Corp.
Provide an overview of the primary business activities
of Enovis Corp.
What unique competitive advantages
does Enovis Corp hold over its rivals?
What risks and challenges
does Enovis Corp face in the near future?
Has there been any significant insider trading activity
in Enovis Corp recently?
Summarize the latest earnings call
of Enovis Corp.
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Enovis Corp.
Provide P/S
for Enovis Corp.
Provide P/E
for Enovis Corp.
Provide P/OCF
for Enovis Corp.
Provide P/FCFE
for Enovis Corp.
Provide P/B
for Enovis Corp.
Provide EV/S
for Enovis Corp.
Provide EV/GP
for Enovis Corp.
Provide EV/EBITDA
for Enovis Corp.
Provide EV/EBIT
for Enovis Corp.
Provide EV/OCF
for Enovis Corp.
Provide EV/FCFF
for Enovis Corp.
Provide EV/IC
for Enovis Corp.
Show me price targets
for Enovis Corp made by professional analysts.
What are the Revenue projections
for Enovis Corp?
How accurate were the past Revenue estimates
for Enovis Corp?
What are the Net Income projections
for Enovis Corp?
How accurate were the past Net Income estimates
for Enovis Corp?
What are the EPS projections
for Enovis Corp?
How accurate were the past EPS estimates
for Enovis Corp?
What are the EBIT projections
for Enovis Corp?
How accurate were the past EBIT estimates
for Enovis Corp?
Compare the revenue forecasts
for Enovis Corp with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Enovis Corp and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Enovis Corp against its competitors.
Analyze the profit margins
(gross, operating, and net) of Enovis Corp compared to its peers.
Compare the P/E ratios
of Enovis Corp against its peers.
Discuss the investment returns and shareholder value creation
comparing Enovis Corp with its peers.
Analyze the financial leverage
of Enovis Corp compared to its main competitors.
Show all profitability ratios
for Enovis Corp.
Provide ROE
for Enovis Corp.
Provide ROA
for Enovis Corp.
Provide ROIC
for Enovis Corp.
Provide ROCE
for Enovis Corp.
Provide Gross Margin
for Enovis Corp.
Provide Operating Margin
for Enovis Corp.
Provide Net Margin
for Enovis Corp.
Provide FCF Margin
for Enovis Corp.
Show all solvency ratios
for Enovis Corp.
Provide D/E Ratio
for Enovis Corp.
Provide D/A Ratio
for Enovis Corp.
Provide Interest Coverage Ratio
for Enovis Corp.
Provide Altman Z-Score Ratio
for Enovis Corp.
Provide Quick Ratio
for Enovis Corp.
Provide Current Ratio
for Enovis Corp.
Provide Cash Ratio
for Enovis Corp.
What is the historical Revenue growth
over the last 5 years for Enovis Corp?
What is the historical Net Income growth
over the last 5 years for Enovis Corp?
What is the current Free Cash Flow
of Enovis Corp?
Discuss the annual earnings per share (EPS)
trend over the past five years for Enovis Corp.
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
Market Cap | EV/EBITDA | ||||
---|---|---|---|---|---|
US |
![]() |
Enovis Corp
NYSE:ENOV
|
1.8B USD | 10.2 | |
US |
![]() |
Abbott Laboratories
NYSE:ABT
|
227.4B USD | 21.9 |
|
US |
![]() |
Intuitive Surgical Inc
NASDAQ:ISRG
|
192.2B USD | 62 |
|
US |
![]() |
Boston Scientific Corp
NYSE:BSX
|
154.6B USD | 35.8 |
|
US |
![]() |
Stryker Corp
NYSE:SYK
|
143.9B USD | 24.9 |
|
IE |
![]() |
Medtronic PLC
NYSE:MDT
|
103.4B USD | 12.5 |
|
DE |
![]() |
Siemens Healthineers AG
XETRA:SHL
|
52.2B EUR | 14 |
|
US |
![]() |
Becton Dickinson and Co
NYSE:BDX
|
49.1B USD | 13 |
|
US |
![]() |
Edwards Lifesciences Corp
NYSE:EW
|
44.1B USD | 24.1 |
|
US |
![]() |
IDEXX Laboratories Inc
NASDAQ:IDXX
|
40.5B USD | 32.1 |
|
CN |
![]() |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
281.2B CNY | 22.1 |
|
EBITDA Growth | EV/EBITDA to Growth | |||||
---|---|---|---|---|---|---|
US |
![]() |
Enovis Corp
NYSE:ENOV
|
Average EV/EBITDA:
24.8
10.2
|
20%
|
0.5 | |
US |
![]() |
Abbott Laboratories
NYSE:ABT
|
21.9
|
13%
|
1.7 |
|
US |
![]() |
Intuitive Surgical Inc
NASDAQ:ISRG
|
62
|
24%
|
2.6 |
|
US |
![]() |
Boston Scientific Corp
NYSE:BSX
|
35.8
|
21%
|
1.7 |
|
US |
![]() |
Stryker Corp
NYSE:SYK
|
24.9
|
12%
|
2.1 |
|
IE |
![]() |
Medtronic PLC
NYSE:MDT
|
12.5
|
5%
|
2.5 |
|
DE |
![]() |
Siemens Healthineers AG
XETRA:SHL
|
14
|
14%
|
1 |
|
US |
![]() |
Becton Dickinson and Co
NYSE:BDX
|
13
|
11%
|
1.2 |
|
US |
![]() |
Edwards Lifesciences Corp
NYSE:EW
|
24.1
|
12%
|
2 |
|
US |
![]() |
IDEXX Laboratories Inc
NASDAQ:IDXX
|
32.1
|
12%
|
2.7 |
|
CN |
![]() |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
22.1
|
16%
|
1.4 |
|
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.